Spectral.DNC-S is indicated for men and women in advanced stages of hair thinning because it delivers numerous compounds performing through complementary pathways.
DS Healthcare Group, Inc. (NASDAQ:DSKX), a leading developer of personal care products, announced today clinical results of a study showing that its Spectral.DNC - S containing a compound sourced as a byproduct of pine production is effective in the promotion of healthy hair and in the cessation of thinning hair in males. Spectral.DNC-S addresses the $3.5 billion spent per year by Americans attempting to treat their hair loss. Spectral.DNC -S is a completely new innovation for the treatment of thinning hair.
After several years of exhaustive research, DS Laboratories has discovered a compound from a natural source which mimic and exceed the activity of pharmaceutical treatments but with greatly reduced side effects. This compound, sourced from pine bark, is believed to act by opening ion channels in cells. It is DS Healthcare’s most potent and advanced formulation to date and provides an entirely new mechanism of action.
The double-blind trial was conducted at Miami Dade Medical Center in Miami, Florida. The subjects were between the ages of 25 and 55 years and had been experiencing active thinning hair. Clinical assessment of scalps of volunteers showed that 85% of subjects had an increase in hair density and 17% had a dramatic improvement. 11% of subjects had no response. “These clinical results provide further evidence that there are many variables involved in overall hair and scalp health, and this in turn for ms the cornerstone of our multivariate approach to therapy. We believe this product line holds great promise for broad commercial success in global markets where we currently have distribution channels,” stated DS Healthcare Group President and CEO, Daniel Khesin.
Most treatments work best in the early stages of hair shedding, before the follicles have a chance to atrophy. But this advanced, minoxidil-free, dual-chamber system also performs well in latter stages of thinning due to the exhaustive research done by DS Laboratories. The company has identified natural compounds that mimic the activities of certain pharmaceuticals, but without the side effects.
These powerful ingredients are delivered through an easily accessible cosmetic product, not a drug. By packaging ingredients in two separate chambers, the delicate materials can be deployed in higher concentrations for higher performance.
Since no topical product yet devised cures hair loss permanently, this product, like minoxidil and other treatments, must be used continuously to continue its benefits.
This new biotechnology means that Spectral.DNC-S can treat follicular dysfunction more aggressively. So, many patients who perceive little or no growth or thickening with minoxidil do see improvement after as little as three months using Spectral.DNC-S.
- ATP synthesis
- Stem cells
- Procyanidin B-2
- Amino acids
- Bioactive peptides
- Collagen/elastin support
- Chemical signaling
- Nanosome encapsulation
Novel ion-channel technologies benefit hair growth, without side effects
Spectral.DNC-S is today's most complex innovation to optimize hair and prevent its thinning because it expresses years of research, contains novel ion-channel openers, and transports key compounds for maximum stability.
Prior to this minoxidil-free formula, many of the most promising combinations of ingredients had proven unstable. But in Spectral.DNC-S, more of these materials can be combined successfully. It is laden with beneficial agents, and a dual-chamber delivery system expands the capacity of one product to contain them all.
In the complex biology of scalp, novel combinations of ion-channel-opening compounds, similar to minoxidil but from natural sources, can mimic pharmaceuticals but without the side effects. In this product, they can be deployed through a unique cosmetic treatment, not a drug.
This new modality shifts the paradigm of hair-follicle care, becoming a new standard to target a wider spectrum of symptoms. The passionate pursuit of more advanced biotechnologies guides all development at DS Laboratories, whose objectives are wide-spectrum activity, long-term efficacy, comfortable wear, and improved overall health.
Spectral.DNC-S means high performance in a healthy environment, unlike minoxidil-based products, which can irritate scalp and leave a greasy, sticky residue.
Follicles cycle through three phases: anagen (growth), catagen (regression), and telogen (resting). In successive cycles, a follicle replaces its hair strand with another that may be either the same size or finer (balding) or thicker (treated). Some ion-channel openers stimulate follicles to produce longer, darker hairs.
Anagen phase may last two to five years for long scalp hairs, or just a few weeks for short body hairs. Rates of growth are similar. In androgenetic alopecia (male pattern baldness), hormones induce follicles to miniaturize and produce vellus (light) hairs.
Despite decades of intense research and interest, our understanding of follicle function remains rudimentary. The oldest known ion-channel opener for hair growth, minoxidil, works only on part of the scalp and only for a subset of users. Plus, it carries side effects.
Greater understanding of how ion-channel openers work is leading to more effective treatments.
DS Laboratories focuses its research on ion channels, the cell-membrane channels selectively permeable to ions such as calcium, sodium, and especially, potassium.
The company searches for new potassium-channel openers by using DiBAC4, a voltage-sensitive fluorescent dye for the measurement of membrane potential. Cells that exhibit decreased fluorescence reveal good channel-opening activities. New, naturally sourced openers are formulated into Spectral.DNC-S.
Channel openers and blockers oppose each other's effects on hair growth. Reverse transcriptase-polymerase chain reaction has identified potassium-channel-component gene expression, including the regulatory sulfonylurea receptors SUR1 and SUR2B. In hair bulbs, epithelial matrix tissues express SUR1, and dermal papilla and sheath tissues exhibit SUR2B.
Recently, UK researchers used several approaches — organ culture, molecular biological, and immunohistological — to confirm that adenosine-triphosphate-sensitive potassium channels were indeed present in human hair follicles. Minoxidil was the first potassium-channel opener widely associated with new hair growth, although its exact mechanism of action remains a mystery.
Since human follicular papilla cells contain ion channels that respond to openers and blockers, new openers targeted to these channels can treat hair-growth disorders.
Potassium channel morphology
Adenosine-triphosphate-sensitive potassium channels are protein channels that control the flow of potassium ions across cell membranes. Diverse compounds can cause them to open or close. Potassium-channel conductance is a control mechanism in hair follicles.
At least 15 types of potassium channels have been classified into four subtypes: voltage dependent, calcium dependent, receptor coupled, and miscellaneous. The potassium channels associated with hair growth work via sensitivity to adenosine triphosphate (ATP). They are complexes of pore-forming, inwardly rectifying, potassium-channel and sulfonylurea-receptor subunits.
These channels link the electrical activity of a cell to its metabolic state, mediating smooth-muscle relaxation, insulin secretion, and neurotransmitter release. Study methods include electrophysiology (electrical properties of cells), direct measurement of potassium flux, and pharmacologic techniques.
Intracellular ATP induces channel inhibition, and ADP induces channel opening. Openers relax smooth muscle and induce hypotension. Some newly identified openers include cyclobutenediones, dihydropyridine-related structures, and tertiary carbinols.
Potassium channel function
In vitro, tiny doses of potassium-channel openers can relax vascular tissues by reducing cellular calcium levels and muscle tone. Conversely, sulfonylureas and other drugs can block ATP-sensitive potassium channels.
The older drugs minoxidil, pinacidil, cromakalim, and nicorandil, as well as some newly discovered channel openers, have been shown to maintain hair growth in vibrissa follicles cultured from primates.
In humans, the openers first associated with hair growth were diazoxide, pinacidil, and minoxidil, which was developed to treat hypertension, then discovered to induce hypertrichosis (hairiness). All of these compounds have been shown to maintain proliferation and differentiation of the epithelium that forms the hair shaft.
More evidence linking potassium-channel openers to hair growth comes from studies with primates that display androgen-dependent balding similar to humans. Multiple channel openers cause hair regrowth in the primates.
Applied topically, potassium channel openers increase hair length, weight, and density by inducing telogen-phase follicles back into anagen phase and by prolonging hair growth. Some compounds also increase blood flow in the scalp. In murine studies, they increased fenestrations (branching) in follicular capillaries, improving blood flow. Not all vasodilators, however, are associated with hair growth.
Adenosine-triphosphate-sensitive potassium channels consist of eight subunits arranged in two rings. The inner ring of four inwardly rectifying channel subunits forms the pore through which potassium ions pass. The outer ring comprises four regulatory sulfonylurea-receptor subunits that can alter channel activity in response to nucleotides or drugs.
By helping to elucidate the forms present in human follicles, DS Laboratories can develop new therapies to promote hair growth, instead of relying on old-style minoxidil.
Another ion-channel under investigation is the epithelial sodium channel. Ionic fluxes in this channel appear to affect critical aspects of keratinocyte differentiation, a key part of hair and skin growth. These activities include the synthesis of key proteins, the enzymatic catalysis of protein cross-linking, and lipid secretion.
In the epithelial sodium channel, alpha and beta subunits are enhanced as keratinocytes differentiate, according to murine studies. When the alpha subunit was inactivated, results included epithelial hyperplasia, abnormal nuclei, and premature secretion of lipids.
The data suggest that the epithelial sodium channel modulates ionic signaling for specific aspects of epidermal differentiation.
To achieve maximum efficacy, Spectral.DNC-S augments its ion-channel-opening capabilities with a wealth of compounds linked to hair growth.
Stem cells from phytosources assist in follicle regeneration. Polyphenol compounds extracted from Malus domestica improve the hairline as well as the vertex. Aminexil® strengthens roots.
Components of this high-performance formula also include copper peptides to stimulate growth, retinol to improve absorption, adenosine for energy transfer, and Panax ginseng root extract for cell longevity.
Stem cells to support follicle regeneration
Spectral.DNC-S outperforms mass-market treatments in part by incorporating plant-based stem cells.
In the scalp, epithelial stem cells differentiate into hair follicles, sebaceous glands, or epidermis. Each lineage maintains its own reservoir of stem cells for the renewal of tissues. In response to disease or injury, the stem cells mobilize to repair tissues whose resident cells have been damaged or removed.
Normally, this robust regenerative capacity maintains hair growth throughout our lifetimes. When follicles malfunction, however, an understanding how stem cells repair wounds is important to an understanding of how they can help to regrow hair.
Morphology: At the site of each hair is a bulge of cells that divide less frequently than other epithelial cells. They are activated at the start of each growth cycle to generate a new follicle.
In one laboratory experiment, stem cells from a single bulge were removed from a hairy mouse and grafted onto a hairless mouse. They generated new follicles that cycled normally. In another study, when confronted with stem cells taken from the wing of a chick, epidermis from its leg actually produced feathers.
Human epidermal cells also show this remarkable plasticity — this feature of “stemness.” Researchers have identified approximately 150 genes expressed preferentially in bulge cells relative to basal cells.
The scalp and its appendages — hair follicles and sebaceous glands — provide protective barriers that keep microbes out and bodily fluids in. They resist wounds and environmental assaults through continuous self renewal.
Hair-growth cycle: Stem cells proliferate in the stratum basale (also called stratum germinativum), which is the basal layer of epidermal cells. They divide to replace the keratin-rich cells of the stratum corneum as those cells migrate toward the surface and slough away.
In the scalp, the primary epidermal appendages are called pilosebaceous units. They contain follicles to manufacture hair and sebaceous glands to lubricate surfaces. Morphogenesis begins with a downward incursion of the epidermis into the underlying dermis to form a placode (area of thickening), in a process dependant on cues from neighboring cells. Underlying dermal cells condense to form a papilla, which is the vascular process that will nourish the root.
The follicle becomes encapsulated in a rich matrix of cells. Then a bulb of stem cells, located midway down the follicular process, proliferates to form an inner root sheath, which will act as a channel to guide the growing hair shaft.
A period of hair growth, called anagen phase, normally lasts a few years. The next phase, called catagen, lasts a few weeks and involves the apoptosis and disappearance of the lower two thirds of the follicle. The dermal papilla migrates up toward the bulge, and the remains of the follicle enter a resting phase, called telogen.
Except when affected by androgenic alopecia (male pattern baldness) or some disease, a single follicle cycles many times throughout a person's life. The cyclic nature of degeneration and regeneration has led to the discovery that stem cells are concentrated in the bulge. Even without alopecia, anagen phase shortens, and telogen phase lengthens in aging scalps.
Stem cells in Spectral.DNC-S: Our new understanding of stem cells means exciting developments in biotechnical formulas for hair. We know that embryonic stem cells can develop into any tissue, that normal skin has reserves of such cells to regenerate itself after wounding, and that stem cells from one animal can develop into hair follicles in another animal.
New applications for stem cells would be to treat hair follicle disorders. Cultured basal epidermal keratinocytes already treat burn patients. However, human stem cells are difficult to access, and their use is fraught with ethical dilemmas.
Spectral.DNC-S overcomes these hurdles by employing plant-based stem cells, which exhibit many of the same properties and much of the same plasticity as human cells. An evolutionary botanical agent derived from plant stem cells now shows evidence of protecting and stimulating human epidermal stem cells and preventing many of the signs of scalp aging.
Current experimentation demonstrates in vitro that active phyto-compounds can stimulate the growth of human mesenchymal stem cells and help to protect them from attack by ultraviolet radiation.
In experiments conducted on hair follicles, plant-based stem-cell extracts have rejuvenated follicular cells and delayed their senescence.
Spectral.DNC-S offers unprecedented new potential to prolong the health of the human scalp and the productivity of its hair follicles, delaying scalp issues.
Polyphenol from Malus domestica extract
Spectral.DNC-S contains procyanidin B-2, a polyphenol derived naturally from Malus domestica, because current research associates the extract with measurable improvement of the hairline as well as the vertex of the scalp.
Epithelial cells of a hair follicle include an outer root sheath, inner root sheath, and bulb matrix. But dermal papilla cells, which nourish the growing root of the hair fiber, are mesenchymal cells, more like bone and connective tissue. Successful hair growth relies on smooth interaction between these two cell types.
Procyanidin B-2 promotes this healthy interaction to allow for anagen-phase hair growth. Such stimulation may be all that is required to overcome some cases of hair thinning. One laboratory study compared hair regrowth after 19 days of treatment with procyanidin B-2, minoxidil, or a placebo. Hair on the backs of mice was shaved, and a topical solution was applied daily. The effectiveness of procyanidin B-2 and minoxidil were similar for inducing anagen-phase hair growth.
In a subsequent double-blind clinical trial with humans, researchers investigated the effects of a 1% procyanidin B-2 solution over four months. Nineteen Japanese men received the procyanidin; 10 received a placebo.
In the procyanidin group, 79 percent showed greater hair diameter, compared to 30 percent in the placebo group. The treated group also showed a higher ratio of hairs over 40 micrometers in diameter and a higher total number of hairs.
This promising research means that Spectral.DNC-S, which delivers procyanidin B-2 in high concentration, applies multiple methods of action to help restore the hairline as well as the vertex.
Aminexil® to strengthen roots
The patented molecule Aminexil (diaminopyrimidine oxide) is one of the most widely studied and proven hair-growth agents because in clinical trials it is shown to protect roots, preserve hair, and strengthen fibers. The compound emerged from 10 years of proprietary research conducted in L'Oreal laboratories.
Hairs can fall out after roots become rigid and compress the blood vessels that nourish them. In androgenic alopecia, the problem starts at both the hairline and vertex, then spreads. Hairs get progressively finer, each with a shorter life span, until they disappear altogether.
Innovative Aminexil prevents this premature aging, called rigidification of collagen. Once captured by the hairs' roots, the Aminexil preserves the suppleness and elasticity of the tissues that surround them. This method of action helps to build new hair fibers thicker, denser, and stronger.
In one trial with 120 men, hair shedding began to slow after as little as three weeks. Hair also became softer to the touch. In a placebo-controlled trial with 130 men, an additional eight percent of hair was maintained in anagen-growth phase after six weeks of Aminexil use.
These clinical results indicate that Spectral.DNC-S, with Aminexil, has the ability to preserve the vital functioning of roots, so they can build more and stronger hair fibers.
Copper-peptide technology to stimulate growth
In Spectral.DNC-S, amino acid groups known as copper peptides have two major properties: 1) as anti-inflammatory agents that limit oxidative damage after tissue injury and 2) as tissue remodeling agents that remove damaged protein and scar tissue and activate their replacement with normal tissue.
Copper peptides are applied to enhance wound healing, they can stimulate the production of collagen, and they may enhance the action of antioxidants. Studies have found that copper peptides improve hair transplant success, increase hair follicle size, stimulate hair growth, and reduce hair loss.
In one study, scientists at the University of San Francisco Wound Center who applied copper peptides to human patients found that severe wounds healed 30 percent faster and that follicular cells displayed significant stimulation.
One tripeptide complex grew new hair in the wound area. The discovery led them to apply the copper peptide complex on a female patient with 90 percent alopecia. After six months, she recovered almost all of her hair. Subsequent tests were conducted with chemotherapy and hair-transplant patients, with great success.
Retinol to improve absorption of key compounds
Spectral.DNC-S incorporates retinol, a fat-soluble form of vitamin A, because it improves the absorption and effectiveness of ion-channel openers and other growth compounds. Often prescribed together, researchers have found that coupling retinol with ion-channel openers can yield better results than with either compound alone.
Vitamin A derivatives such as retinol get absorbed by the skin directly, increasing its turnover rate and building collagen for a more youthful appearance. The antioxidant maintains epithelial cell types as physical barriers against infection; builds immune system cells including B-cells, T-cells, and natural killer cells; and affects production of human growth hormone.
For hair, retinol's greatest effect is to control the functioning of sebaceous glands, which produce sebum, a complex mixture of lipids that reduces water loss and protects the skin from infection. But sebum also contains dihydrotestosterone, the hormone responsible for baldness. Moderating sebaceous glands can lower this damaging agent.
Spectral.DNC-S applies retinol directly to the site of follicular challenge, so it enhances the performance of ion-channel openers and other beneficial agents to help prevent and reverse the shedding of hair.
Adenosine for energy transfer in follicles
The adenosine nucleoside plays an important role in hair growth because it works in biochemical processes like energy transfer (adenosine triphosphate, adenosine diphosphate) and signal transduction (cyclic adenosine monophosphate).
This potent anti-inflammatory is under much study for hair growth and wound healing. For androgenic alopecia, adenosine is believed to regulate the expression of fibroblast growth factor 7 and vascular endothelial growth factor in dermal papilla cells.
Investigators assessed 101 volunteers in a randomized double-blind trial, comparing an adenosine 0.75% topical lotion against one with niacinamide 0.1%. They applied the lotions twice daily for six months, then evaluated the ratio of vellus (light) hairs to terminal (thick) hairs. For increasing the ratio of terminal hairs, as well as for global improvement, adenosine proved superior to niacinamide, producing a higher ratio of terminal hairs and lower ratio of vellus hairs. Side effects were not found.
This emerging science means that adenosine in Spectral.DNC-S can stimulate hair without side effects to help users restore their normal lifestyles.
Citrulline to supplement amino-acid deficiency
Spectral.DNC-S is fortified with citrulline, a crystalline amino acid formed in the conversion of ornithine to arginine and found in the inner root sheath and medulla of hair follicles.
Citrullinemia, a disorder of amino-acid metabolism, is associated with skin and scalp changes like atrophy of the epidermis, thin and short collagen bundles, and dystrophic elastic fibers. With a diagnosis of reduced citrulline, researchers have noted changes such as brittle blond strands and the presence of transverse opaque bands.
Amino-acid analysis has shown that relaxers used to straighten African hair often damage the strands, leaving them shorter than expected. A decrease in citrulline was found in all relaxed hair studied. Relaxers have been associated with inflammation as well.
The citrulline formulated into Spectral.DNC-S helps to supplement any deficiency.
Panax ginseng root extract for longevity
Modern scientific evidence indicates that roots of the genus Panax, commonly called ginseng, may prolong hair-follicle life, exert antioxidant effects, boost the immune system, and provide other benefits.
Several plant extracts have been investigated for their ability to influence apoptosis, the genetically determined process of cellular self destruction. In multiple studies of murine hair follicles, ginseng prevented apoptosis. It also aided the formation of medullary cells, even after application of gamma radiation.
Modulating the apoptotic process is of great interest to researchers, both for stimulating cell death, as in treatments to oppose cancer cells, and for inhibiting cell death, as in treatments to promote hair follicle growth.
A hydrolyzed ginseng-saponin quaternary has been developed as a conditioning agent for the next generation of hair-care products. Its structure includes a hydrophobic group from the aglycon of ginseng saponin, which is biologically active and considered to be its most important therapeutic component.
Properties of surface tension, conductivity, critical micelle concentration, absorption into hair, tensile strength, and moisture retention have been demonstrated scientifically.
Spectral.DNC-S delivers effectiveness with a better feel. Spectral.DNC-S delivers later-stage hair-recovery effectiveness for both men and women, while maintaining a pleasant texture and a healthy environment for the scalp, unlike formulas with generic minoxidil, which leaves a greasy, sticky residue, and can be irritating for many.
Spectral.DNC-S is a completely new innovation for the treatment of thinning hair. After several years of exhaustive research, DS Laboratories has discovered several compounds from natural sources which mimic and exceed the activity of pharmaceutical treatments but with greatly reduced side effects. These compounds are deployed in a unique cosmetic formulation. It is our most potent and advanced formulation to date and provides an entirely new mechanism of action.
Furthermore, this formulation utilizes powerful ingredients in two separate chambers that enables the use of materials thatg are otherwise not compatible and also a higher concentration of ingredients then a single formulation could hold.
Ion channels. Multiple ingredients open ion channels within scalp cells to enable the flow of proteins and enzymes for superior results.
Dihydrotestosterone. Key ingredients control DHT production to help keep follicles healthy and normal. Botanicals.Extensive use of botanical compounds, instead of chemicals such as minoxidil and finasteride, delivers hair-health benefits naturally.
Dual-chamber system. Separate chambers keep ion-channel openers and synergistic compounds stable until users combine them for maximum activity.
The wide-spectrum actions of Spectral.DNC-S together with the high-performance standards of DS Laboratories mean long-term efficacy, comfortable wear, and overall health improvement. So users enjoy a quick, significant impact on texture and fullness, plus compounded benefits longer term.
Spectral.DNC-S come for two month supply, 2 in 1.
Contraindications: This formulation is contraindicated in individuals with a history of sensitivity reactions to any of this components. It should be discontinued if hypersensitivity to any of its ingredients is noted.
Warning: Do not use if pregnant or breast feeding.
Directions for use: Shake well before use: Apply 6 sprays directly in the area of thinning hair, twice per day. Massage the solution into the scalp. Do not rinse. Spectral.DNC-S should be applied whether your hair has been washed or not. For best result, hair should be washed at least 5 times per week. Regular use, on a consistent schedule without skipping applications is critical.
For topical use only. Not for ophthalmic, oral, or intravaginal use.
INGREDIENTS SOLUTION 1: DEIONIZED WATER, PALMITOYL PINE BARK EXTRACT, PROPYLENE GLYCOL, ADENOSINE, BIOFLAVONOID COMPLEX (PINE BARK EXTRACT, SERENOA SERRULATA EXTRACT, CAMELIA SINENSIS EXTRACT, ZEA MAYS (CORN) GLUTEN PROTEIN, SALIX ALBA BARK EXTRACT, PUNICA GRANATUM EXTRACT, CAPSICUM, THYMUS VULGARIS (THYM) EXTRACT, GINSENG EXTRACT), PYRROLIDINYL DIAMINOPYRIMIDINE OXIDE, DIAMINOPYRIMIDINE OXIDE, ACETYLSALICYLIC ACID, ETHYLBISIMINOMETHYLGUAIACOL MANGANESE CHLORIDE (EUK-134), RETINOL, MALUS DOMESTICA FRUIT CELL CULTURE EXTRACT (STEM CELLS), AZELAIC ACID, CALCIUM PANTHOTHENATE, PYRIDOXINE HYDROCHLORIDE, PHOSPHOLIPIDS (NANOSOMES), BIOTINOYL TRIPEPTIDE-1, MYRISTOYL PENTAPEPTIDE-17, OCTAPEPTIDE-2, ARGAN OIL, PREZATIDE COPPER ACETATE, PHENOXYETHANOL, CAPRYLYL GLYCOL, SORBIC ACID
INGREDIENTS SOLUTION 2: DEIONIZED WATER, GLYCERIN, ARGININE, ACETYL TYROSINE, GLYCINE, ARCTIUM MAJUS ROOT EXTRACT, HYDROLYZED SOY PROTEIN, POLYQUATERNIUM 11, POLYSILOXANE, POLYALKYLENE, COPOLYMER, CALCIUM PANTOTHENATE, ZINC GLUCONATE, NIACINAMIDE, ORNITHINE HYDROCHLORIDE, PROCYANIDIN B-2, CITRULLINE, GLUCOSAMINE HYDROCHLORIDE, BIOTIN, LYSINE, HISTIDINE, ASPARTIC ACID, THREONINE, SERINE, GLUTAMIC ACID, PROLINE, ALANINE, VALINE, METHIONINE, ISOLEUCINE, LEUCINE, GLUCOSE, TYROSINE, HENYLALANINE, CYSTEINE, ARCTIUM MAJUS ROOT EXTRACT, DEXTRAN, TRIPEPTIDE-1, DIMETHYLSULFONE, PHENOLSULFONEPHTHALEIN, PHENOYETHANOL, CAPRYLYL GLYCOL
Q: What type of results should I expect?
A: You can expect your hair to look and feel fuller and thicker. Most importantly, this can be maintained with continued use.
Q: Is stress a factor for thinning hair?
A: When the body is under significant pshical and emotional stress it is possible that the immune system will produce anti-bodies that attack the hair follicles and this results in bald patches or diffuse loss. Additionally, latest research in laboratory animals shows that stress produces certain hormonesc which can directly affect hair.
Q: What is DHT?
A: Dihydrotestosterone (DHT) is belived to be the cause of male pattern baldness. DHT is formed from testosterone when testosterone comes in contact with oil glands in the hair follicles. DHT gets in to the hair follicles and shrinks them. At the same time, it makes the protective membrane of the scalp thicken, restricting blood flow to the capillaries. This gradully causes hair loss.
Q: What side effects are there to using Spectral.DNC-S?
A: Spectral.DNC-S has no known side effects. However, it should used with caution and immediately discontinued if any reaction or irritation is observed. If you have any doubts, speak to your doctor.
Q: How effective is Spectral.DNC-S?
A: You can expect dramatic results from your Spectral.DNC-S treatment. It is the most unique and potent treatment from DS Laboratories.
Q: Who is the ideal candidate for Spectral.DNC-S?
A: The ideal Spectral.DNC-S candidate is someone with generalized thinning hair. Spectral.DNC-S is also ideal for individuals who want to mantain maximum hair vitality and scalp health.
Q: When should I expect to see results from Spectral.DNC-S?
A: Three months is the average amount of time necessary to observe results, although some users may see results sooner.
Q: Can I use Spectral.DNC-S once per day insteand of twice?
A: For Spectral.DNC-S to be used effectively, it must be used twice per day, preferably morning and before bedtime. However, once desired results are achieved they can be maintained with once daily application. If you notice a decline then you can return to twice per day usage.
Q: Can I skip a treatment or two of Spectral.DNC-S?
A: You can occasionally skip a treatment without reducing effectiveness, however, we generally see that users with best results maintain a regular treatment schedule.
Q: Can i stop using Spectral.DNC-S after achieving desired results?
A: Yes, Spectral.DNC-S can be discontinued once desirable results have been achieved. However, some people may want to continue the treatment indefinitely to maintain the best possible hair and scalp health.
Q:What shampoo should I use?
A: We recommend using a mild shampoo, free of sodium laureate sulfate. It is also best to wash your hair every day to keep the scalp clean at all times.If you suffer from dandruff or seborrhea you can use a dandruff shampoo several times per week.
Q: Can I blow dry my hair after using Spectral.DNC-S?
A: You should apply Spectral.DNC-S after blow drying. Blow drying can cause some of the solution to evaporate and is not recommended.
Q: Can I use hair sprays, mousses, gels etc?
A: Hair sprays, gel, and other styling aids are not recommended since they tend to clog the hair shaft. However if you visit on using styling aids then you should apply Spectral.DNC-S first and wait for it to dry completely before applying styling aids.
Q: Can I have my hair colored or permed while using Spectral.DNC-S?
A: Coloring or perming hair is generally not recommended. If it must be done, try to use the least irritating and mild products.
Q: Can I go swimming or get my hair wet?
A: You should avoid washing off Spectral.DNC-S after it has been applied. You should avoid washing off Spectral.DNC-S for at least 3 hours after application. If you plan on swimming it is recommended to apply Spectral.DNC-S immediately after swimming on dry scalp or wait at least 3 hours after application.